Impact of closed loop stimulation on prognostic cardiopulmonary variables in patients with chronic heart failure and severe chronotropic incompetence: a pilot, randomized, crossover study.

Cardiac resynchronization therapy Cardiopulmonary exercise testing Closed loop stimulation Rate-adaptive pacing Severe chronotropic incompetence Ventilatory efficiency slope

Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
08 11 2021
Historique:
received: 28 10 2020
accepted: 30 04 2021
pubmed: 14 5 2021
medline: 1 4 2022
entrez: 13 5 2021
Statut: ppublish

Résumé

Clinical effects of rate-adaptive pacing in heart failure patients with chronotropic incompetence (CI) undergoing cardiac resynchronization therapy (CRT) remain unclear. Closed loop stimulation (CLS) is a new rate-adaptive sensor in CRT devices. We evaluated the effectiveness of CLS in CRT patients with severe CI, focusing primarily on key prognostic variables assessed by cardiopulmonary exercise (CPX) testing. In the randomized, crossover, multicentre BIO|CREATE study, 20 CRT patients with severe CI and NYHA Class II/III (60%/40%) were randomized 1:1 to the sequence DDD-40 mode to DDD-CLS mode, or the sequence DDD-CLS mode to DDD-40 mode (1 month in each mode). Patients underwent symptom-limited treadmill-based CPX test in each mode. An improvement (decrease) of the ventilatory efficiency (VE) slope of ≥5% during CLS was regarded as positive response to CLS. Seventeen patients with full data sets had a mean intra-individual VE slope change of -1.8 ± 3.0 (-4.1%) with CLS (P = 0.23). Eight patients (47%) were CLS responders, with a -6.1 ± 2.7 (-16.4%) slope change (P = 0.029). Compared to non-responders, CLS responders had a higher left ventricular (LV) ejection fraction (46 ± 3 vs. 36 ± 9%; P = 0.0070), smaller end-diastolic LV volume (121 ± 34 vs. 181 ± 41 mL; P = 0.0085), smaller end-systolic LV volume (65 ± 23 vs. 114 ± 39 mL; P = 0.0076), and were predominantly in NYHA Class II (P = 0.0498). The data of the present pilot study are compatible with the notion that CLS activation may improve VE slope in CRT patients with severe CI and less advanced heart failure. Further research is needed to determine the long-term clinical outcomes of CLS.

Identifiants

pubmed: 33982093
pii: 6274946
doi: 10.1093/europace/euab110
pmc: PMC8576282
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1777-1786

Commentaires et corrections

Type : CommentIn

Informations de copyright

© The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology.

Références

J Cardiovasc Electrophysiol. 2009 Jul;20(7):773-80
pubmed: 19207785
Open Cardiovasc Med J. 2010 May 26;4:127-34
pubmed: 20657715
Circulation. 2011 Mar 8;123(9):1010-20
pubmed: 21382903
Herzschrittmacherther Elektrophysiol. 2000 Dec;11(4):244-53
pubmed: 27515355
Circ Heart Fail. 2018 Aug;11(8):e004969
pubmed: 30354566
Pacing Clin Electrophysiol. 2004 Jan;27(1):24-32
pubmed: 14720151
Eur J Cardiovasc Prev Rehabil. 2008 Apr;15(2):197-202
pubmed: 18391648
JACC Heart Fail. 2018 Feb;6(2):105-113
pubmed: 29226818
J Am Coll Cardiol. 2016 Apr 26;67(16):1885-96
pubmed: 27102504
J Am Coll Cardiol. 2005 Dec 20;46(12):2292-7
pubmed: 16360061
Eur J Heart Fail. 2014 Feb;16(2):201-9
pubmed: 24464973
Circulation. 2000 Jun 20;101(24):2803-9
pubmed: 10859285
J Cardiovasc Electrophysiol. 2012 Dec;23(12):1317-25
pubmed: 22830441
Europace. 2011 Oct;13(10):1459-63
pubmed: 21551475
Eur Heart J. 2013 Aug;34(29):2271-80
pubmed: 23315907
Europace. 2008 Mar;10(3):327-33
pubmed: 18272507
Eur J Heart Fail. 2008 Jan;10(1):96-101
pubmed: 18096432
Circ Heart Fail. 2010 May;3(3):405-11
pubmed: 20200329
N Engl J Med. 2005 Apr 14;352(15):1539-49
pubmed: 15753115

Auteurs

Joachim Proff (J)

Medizinische Klinik für Kardiologie, Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.

Béla Merkely (B)

Heart and Vascular Center, Semmelweis Medical University, Városmajorutca 68, 1122 Budapest, Hungary.

Roland Papp (R)

Heart and Vascular Center, Semmelweis Medical University, Városmajorutca 68, 1122 Budapest, Hungary.

Corinna Lenz (C)

Klinik für Innere Medizin/Kardiologie, Unfallkrankenhaus Berlin, Warener Str. 7, 12683 Berlin, Germany.

Peter Nordbeck (P)

Medizinische Klinik I, Universitaetsklinikum Wuerzburg, Oberdürrbacher Str. 6, 97080 Wuerzburg, Germany.

Christian Butter (C)

Kardiologie, Herzzentrum Brandenburg in Bernau & Medizinische Hochschule Brandenburt, Ladeburger Str. 17, 16321 Bernau bei Berlin, Germany.

Juergen Meyerhoefer (J)

Innere Medizin - Kardiologie und Chest Pain Unit, Maria Heimsuchung-Caritas-Klinik Pankow, Breite Str. 46/47, 13187 Berlin, Germany.

Michael Doering (M)

Abteilung für Rhythmologie, Herzzentrum Leipzig, Struempellstr. 39, 04289 Leipzig, Germany.

Dean J MacCarter (DJ)

1324 Castle Point Circle, Castle Pines, CO, USA.

Katharina Ingel (K)

Center for Clinical Research, BIOTRONIK SE & Co. KG, Woermannkehre 1, 12359 Berlin, Germany.

Thomas Thouet (T)

Charite Universitaetsmedizin Berlin, Abteilung Sportmedizin, Philippstraße 13, Haus 11, 10115 Berlin, Germany.

Ulf Landmesser (U)

Medizinische Klinik für Kardiologie, Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.

Mattias J Roser (MJ)

Medizinische Klinik für Kardiologie, Charite Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hindenburgdamm 30, 12203 Berlin, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH